This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Bioinformatics Platform industry.
What is the anticipated market size of the bioinformatics platform industry over the next few years?
The bioinformatics platform market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing focus on systems biology and integrative omics, increasing collaborations between research institutes and biotech firms, rising awareness of the benefits, growing number of bioinformatics-enabled startups, increasing government initiatives and funding in genomics research.
The bioinformatics platform market size is expected to see strong growth in the next few years. It will grow to $14.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising volume of biological and genomic data, growing investments in drug discovery and development, increasing adoption of cloud-based bioinformatics solutions, rising application of bioinformatics in agriculture and food security. Major trends in the forecast period include advancements in genomics and precision medicine, advancements in AI and machine learning algorithms, integration of cloud-based bioinformatics solutions, integration of multi-omics data analysis, and technology adoption in clinical diagnostics and biomarker discovery.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23641&type=smp
What emerging drivers are expected to shape the future of the bioinformatics platform market?
The increasing adoption of personalized medicine is anticipated to propel the growth of the bioinformatics platform market in the coming years. Personalized medicine is an approach to healthcare that customizes treatment and prevention strategies based on an individual’s specific genetic profile, lifestyle choices, and environmental influences. The demand for personalized medicine is rising due to advances in genomic technologies, which enable precise identification of genetic variations linked to diseases, allowing for more targeted and effective treatments. The growing demand for personalized medicine drives the need for advanced bioinformatics platforms, as they are essential for analyzing and interpreting vast amounts of genomic and clinical data to develop individualized treatment plans. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA authorized 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals granted in 2022. Therefore, the increasing adoption of personalized medicines will boost the growth of the bioinformatics platform market.
What emerging segments are shaping the future landscape of the bioinformatics platform industry?
The bioinformatics platform market covered in this report is segmented –
1) By Platform Type: Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural And Functional Analysis Platforms, Other Platforms
2) By Application: Genomics, Proteomics, Drug Discovery, Personalized Medicine, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Other End Users
Subsegments:
1) By Sequence Analysis Platforms: Whole Genome Sequencing (WGS) Platforms, Targeted Sequencing Platforms, RNA Sequencing Platforms, Metagenomic Sequencing Platforms, Exome Sequencing Platforms
2) By Sequence Alignment Platforms: Global Alignment Tools, Local Alignment Tools, Pairwise Alignment Tools, Multiple Sequence Alignment Tools, Structural Alignment Tools
3) By Sequence Manipulation Platforms: Sequence Assembly Tools, Sequence Editing Tools, Sequence Visualization Tools, Sequence Conversion Tools
4) By Structural And Functional Analysis Platforms: Protein Structure Prediction Tools, Structural Bioinformatics Tools, Functional Annotation Tools, Molecular Docking Platforms, Pathway Analysis Tools
5) By Other Platforms: Data Integration Platforms, Data Visualization Platforms, Bioinformatics Workflow Management Platforms, Cloud-Based Bioinformatics Platforms
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/bioinformatics-platform-global-market-report
What are the key trends shaping the bioinformatics platform market in the forecast period?
Major companies operating in the bioinformatics platform market are developing technologically advanced solutions, such as multiomic data mapping platforms, to provide accurate insights and a better understanding of complex diseases and conditions. Multiomic data mapping platforms are integrated systems that analyze and correlate data from multiple biological layers, such as genomics, transcriptomics, proteomics, and metabolomics, to provide a comprehensive understanding of complex biological processes. For instance, in February 2023, BioSkryb Genomics, a US-based biotechnology company, launched the BaseJumper Bioinformatics Platform. This platform is designed to enhance the ResolveOME system by simplifying large-scale single-cell informatics. It enables quick organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining data interpretation. The platform offers dynamic filtering and a suite of visualization tools, allowing researchers across disciplines to easily analyze and visualize complex datasets.
How are key players in the bioinformatics platform market strengthening their market position?
Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., International Business Machines Corporation, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Bio-Rad Laboratories Inc., Waters Corporation, Bruker Corporation, Partek Incorporated, Qiagen N.V., NeoGenomics Laboratories Inc., Genedata AG, ID Business Solutions, DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc.
Which geographic areas are contributing significantly to the growth of the bioinformatics platform sector?
North America was the largest region in the bioinformatics platform market in 2024. The regions covered in the bioinformatics platform market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Bioinformatics Platform Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=23641&type=smp
Need Customized Data On Bioinformatics Platform Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=23641&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
